Neonatologists
Rapid interpretation of oxygenation and perfusion status.
Clinical context
Preterm newborns require rapid and trustworthy oxygenation and perfusion assessment during a highly dynamic physiological transition after birth.
During the first minutes after birth, clinicians work under time pressure while the newborn may have low peripheral perfusion, movement, wet skin, fragile skin, and very small extremities. These conditions can make optical oxygenation and perfusion signals difficult to acquire or interpret.
Birth
Standard neonatal assessment begins, while optical oxygenation and perfusion signals may not yet be stable.
3 minutes
Optical signals may still be delayed or unstable due to low perfusion, motion, wet skin, or poor contact.
10 minutes
Teams need confidence that optical trends reflect physiology rather than artifact or sensor failure.
Early NICU
Signal trustworthiness remains important during ongoing fragile monitoring and sensor repositioning.
The challenge is not the absence of monitoring. The challenge is uncertainty: is the optical signal clinically trustworthy, or is it affected by artifact?
Current neonatal monitoring relies on ECG-based heart-rate assessment, preductal pulse oximetry, and integrated patient-monitoring systems. NeoPerfuse respects this standard of care and focuses on the residual gap: earlier trustworthy optical oxygenation/perfusion information under difficult preterm-transition conditions.
Rapid interpretation of oxygenation and perfusion status.
Reduced repeated sensor repositioning and clearer signal feedback.
Faster confidence during early transition.
Improved transparency in unstable monitoring windows.
Structured signal-quality and workflow data.
NeoPerfuse addresses signal delay, instability, and uncertainty in the first critical minutes of preterm neonatal care. The aim is not to replace established monitors, but to make optical signal reliability more explicit.
Collaboration